What's breaking now, across thousands of outlets.
(RTTNews) - Drugmaker Eli Lilly and Co. (LLY), announced on Monday that it has expanded its collaboration and license agreement with biotechnology firm Gate Bioscience to discover and develop molecular gate therapeutics, adding one new target with the option for a second.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
MOH, CoG and SHA agree on county facility contracts, 90-day payment for clean claims and a 30-day moratorium on five compliance documents as new contracting starts Monday.
As daylight hours shrink each fall, the body responds in measurable ways, from sleep shifts to mood changes and cravings
Experten bemängeln, dass die Pflegereform nicht auf struktureller Ebene ansetzt. Was kann sich Deutschland im Ausland abschauen? Drei Länder, drei Ansätze, Pflege anders zu organisieren.
Shionogi is buying an Austin, TX-based commercial biotech for $2 billion upfront, adding another medicine to the Japanese pharma's rare disease portfolio.
A lab accident is said to have led to the death of a woman from pneumonic plague in the Irkutsk region of Siberia, leading to nearly 200 possible contacts being put under observation
The Children’s Hospital in North Karachi is set for revival after months of closure, with a new administration scheduled to … Read More The post Karachi Children’s Hospital Set for Revival After…
